Liverpool School of Tropical Medicine

#Clinical trial #Liverpool School of Tropical Medicine

Ophirex to produce snake venom inhibitor for LSTM study 

Public benefit corporation Ophirex has entered an agreement to produce a snake venom inhibitor for the Liverpool School of Tropical Medicine (LSTM).  Marimastat is an inhibitor of snake venom metalloproteinases, a major snake venom toxin which plays a primary role in the digestion of tissues, leading to swelling, necrosis and internal… Read More

#News

Cobra
#Drug repurposing #Liverpool School of Tropical Medicine #LMICs #University of Sydney #World Health Organization

Heparin provides a cheap antidote for cobra bites

Scientists at the University of Sydney and Liverpool School of Tropical Medicine have revealed that a commonly used blood thinner, heparin, can be repurposed as an inexpensive antidote for cobra venom. Cobras kill thousands of people a year worldwide and many more are seriously maimed by… Read More

#News

Antibodies
#Antibodies #Collaboration #Funding #Infectious diseases #LifeArc #Liverpool School of Tropical Medicine

Infectious diseases research fund will progress antibody therapies

Liverpool School of Tropical Medicine (LSTM) and LifeArc are partnering to launch a new Translational Development Fund to help tackle infectious diseases. LifeArc will invest £2.7 ($3.4) million into the fund, which will support the progression of new technologies and treatments for emerging viral threats and… Read More

#News